U.S. Anatomic Pathology Market (2025 - 2030) Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery & Development), By End Use, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product & Services
                        1.2.2. Application
                        1.2.3. End Use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market formulation & Validation
                    1.7. Model Details
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product & services outlook
                        2.2.2. Application outlook
                        2.2.3. End use outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Anatomic Pathology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. Anatomic Pathology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. U.S. Anatomic Pathology Market: Pipeline Analysis
Chapter 4. U.S. Anatomic Pathology Market: Product & Services Estimates & Trend Analysis
                    4.1. Product & Services Segment Dashboard
                    4.2. U.S. Anatomic Pathology Market: Product & Services Movement Analysis
                    4.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Billion)
                    4.4. Instruments
                        4.4.1. Microtomes & Cryostat microtomes
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.4.2. Tissue processors
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.4.3. Automatic strainers
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.4.4. Whole Slide Imaging (WSI) Scanners
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.4.5. Other products
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                    4.5. Consumables
                        4.5.1. Reagents & Antibodies
                            4.5.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.5.2. Probes & Kits
                            4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                        4.5.3. Others
                            4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
                    4.6. Services
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Anatomic Pathology Market: Application Estimates & Trend Analysis
                    5.1. Application Segment Dashboard
                    5.2. U.S. Anatomic Pathology Market: Application Movement Analysis
                    5.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
                    5.4. Disease Diagnosis
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                    5.5. Drug Discovery and Development
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                    5.6. Others
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Anatomic Pathology Market: End Use Estimates & Trend Analysis
                    6.1. End Use Segment Dashboard
                    6.2. U.S. Anatomic Pathology Market: End Use Movement Analysis
                    6.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
                    6.4. Hospitals
                        6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                    6.5. Research Laboratories
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                    6.6. Diagnostic Laboratories
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                    6.7. Others
                        6.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. Key company heat map analysis, 2024
                    7.4. Company Profiles
                        7.4.1. Danaher Corporation
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Quest Diagnostics Incorporated
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Labcorp
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Agilent Technologies, Inc.
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Cardinal Health
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. Sakura Finetek USA, Inc.
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. NeoGenomics Laboratories, Inc.
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. BioGenex
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. Bio SB
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. anatomic pathology market, by product & services, 2018 - 2030 (USD Billion)
Table 3 U.S. anatomic pathology market, by application, 2018 - 2030 (USD Billion)
Table 4 U.S. anatomic pathology market, by end use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. anatomic pathology market: market outlook
Fig. 10 U.S. anatomic pathology competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. anatomic pathology market driver impact
Fig. 16 U.S. anatomic pathology market restraint impact
Fig. 17 U.S. anatomic pathology market strategic initiatives analysis
Fig. 18 U.S. anatomic pathology market: Product & services movement analysis
Fig. 19 U.S. anatomic pathology market: Product & services outlook and key takeaways
Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
Fig. 21 Microtomes & cryostat microtomes market estimates and forecasts, 2018 - 2030
Fig. 22 Tissue processors market estimates and forecasts, 2018 - 2030
Fig. 23 Automatic strainers market estimates and forecasts, 2018 - 2030
Fig. 24 Whole Slide Imaging (WSI) scanners market estimates and forecasts, 2018 - 2030
Fig. 25 Other products market estimates and forecasts, 2018 - 2030
Fig. 26 Consumables market estimates and forecasts, 2018 - 2030
Fig. 27 Reagents & antibodies market estimates and forecasts, 2018 - 2030
Fig. 28 Probes & kits market estimates and forecasts, 2018 - 2030
Fig. 29 Others market estimates and forecasts, 2018 - 2030
Fig. 30 Services market estimates and forecasts, 2018 - 2030
Fig. 31 U.S. anatomic pathology market: Application movement analysis
Fig. 32 U.S. anatomic pathology market: Application outlook and key takeaways
Fig. 33 Disease diagnosis market estimates and forecasts, 2018 - 2030
Fig. 34 Drug discovery and development market estimates and forecasts, 2018 - 2030
Fig. 35 Others market estimates and forecasts, 2018 - 2030
Fig. 36 U.S. anatomic pathology market: End use movement analysis
Fig. 37 U.S. anatomic pathology market: End use outlook and key takeaways
Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030
Fig. 39 Research laboratories market estimates and forecasts, 2018 - 2030
Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 41 Others market estimates and forecasts, 2018 - 2030